New Hampshire bills · 2026 Regular Session

New Hampshire SB 256

establishing safety and care requirements for clinician-administered drugs.

1. Introduced
2. In committee
3. Passed Senate
4. Passed House
5. To Governor
6. Became law

Sponsors

No sponsor recorded.

Cosponsors (1)

• John Michael Potucek

Summary

Roll-call votes

No recorded votes on this bill.

Actions

• Oct 1, 2026 · House
  Executive Session: 10/14/2026 10:00 am GP 229
• Sep 17, 2026 · House
  Subcommittee Work Session: 10/07/2026 10:00 am GP 229
• Aug 21, 2026 · House
  Subcommittee Work Session: 09/09/2026 10:00 am GP 229
• May 14, 2026 · House
  Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2
• May 1, 2026 · House
  Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6
• Apr 22, 2026 · House
  Executive Session: 04/29/2026 10:00 am GP 229
• Apr 16, 2026 · House
  Subcommittee Work Session: 04/22/2026 10:00 am GP 229
• Apr 2, 2026 · House
  Public Hearing: 04/07/2026 02:15 pm GP 159
• Apr 1, 2026 · House
  Subcommittee Work Session: 04/08/2026 10:00 am GP 229
• Mar 2, 2026 · House
  Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127
• Feb 26, 2026 · House
  Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124
• Jan 7, 2026 · Senate
  Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
• Jan 7, 2026 · Senate
  Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1
• Oct 22, 2025 · Senate
  Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
• Mar 6, 2025 · Senate
  Rereferred to Committee, MA, VV; 03/06/2025; SJ 6
• Feb 21, 2025 · Senate
  Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11
• Feb 5, 2025 · Senate
  Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9
• Jan 23, 2025 · Senate
  Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3